Pharsight

Drugs that contain Ethinyl Estradiol; Levonorgestrel

1. Balcoltra patents expiration

BALCOLTRA IPR and PTAB Proceedings
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US6716814 AVION PHARMS Enhancing solubility of iron amino acid chelates and iron proteinates
Aug, 2021

(2 years ago)

US7838042 AVION PHARMS Hypoallergenic metal amino acid chelates and metal amino acid chelate-containing compositions
Jun, 2027

(3 years from now)

Market Authorisation Date: 09 January, 2018

Treatment: Administration of ferrous bisglycinate tablets

Dosage: TABLET;ORAL

How can I launch a generic of BALCOLTRA before it's drug patent expiration?
More Information on Dosage

BALCOLTRA family patents

Family Patents

2. Loseasonique patents expiration

LOSEASONIQUE's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7615545 TEVA BRANDED PHARM Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
Jun, 2023

(11 months ago)

US7858605 TEVA BRANDED PHARM Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
Jun, 2023

(10 months ago)

US7855190 TEVA BRANDED PHARM Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
Dec, 2028

(4 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Product(NP) Oct 24, 2011

Market Authorisation Date: 24 October, 2008

Treatment: Prevention of pregnancy

Dosage: TABLET;ORAL

How can I launch a generic of LOSEASONIQUE before it's drug patent expiration?
More Information on Dosage

LOSEASONIQUE family patents

Family Patents

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

3. Lybrel patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6500814 WYETH PHARMS INC Hormonal contraceptive
Sep, 2018

(5 years ago)

Market Authorisation Date: 22 May, 2007

Treatment: Prevention of pregnancy

Dosage: TABLET;ORAL

How can I launch a generic of LYBREL before it's drug patent expiration?
More Information on Dosage

LYBREL family patents

Family Patents

4. Preven Emergency Contraceptive Kit patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6156742 TEVA BRANDED PHARM Emergency contraceptive kit
Dec, 2020

(3 years ago)

Market Authorisation Date: 01 September, 1998

Treatment: Kit adapted and designed to provide both data on the current reproductive status of a patient and contraception for those who are not pregnant, but recently engaged in unprotected sex

Dosage: TABLET;ORAL

More Information on Dosage

PREVEN EMERGENCY CONTRACEPTIVE KIT family patents

Family Patents

5. Quartette patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8450299 TEVA BRANDED PHARM Methods of hormonal treatment utilizing ascending-dose extended cycle regimens
Oct, 2025

(1 year, 4 months from now)

US8415332 TEVA BRANDED PHARM Methods of hormonal treatment utilizing ascending-dose extended cycle regimens
Mar, 2029

(4 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Product(NP) Mar 28, 2016

Market Authorisation Date: 28 March, 2013

Treatment: Prevention of pregnancy

Dosage: TABLET;ORAL

How can I launch a generic of QUARTETTE before it's drug patent expiration?
More Information on Dosage

QUARTETTE family patents

Family Patents

6. Seasonale patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5898032 TEVA BRANDED PHARM Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
Jun, 2017

(6 years ago)

USRE39861 TEVA BRANDED PHARM Methods of extended use oral contraception
Jun, 2017

(6 years ago)

Market Authorisation Date: 05 September, 2003

Treatment: Prevention of pregnancy; Prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception

Dosage: TABLET;ORAL

How can I launch a generic of SEASONALE before it's drug patent expiration?
More Information on Dosage

SEASONALE family patents

Family Patents

7. Seasonique patents expiration

SEASONIQUE's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7615545 TEVA BRANDED PHARM Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
Jun, 2023

(11 months ago)

US7858605 TEVA BRANDED PHARM Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
Jun, 2023

(10 months ago)

US7320969 TEVA BRANDED PHARM Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
Jan, 2024

(3 months ago)

US7855190 TEVA BRANDED PHARM Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
Dec, 2028

(4 years from now)

Market Authorisation Date: 25 May, 2006

Treatment: Prevention of pregnancy; Prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception

Dosage: TABLET;ORAL

How can I launch a generic of SEASONIQUE before it's drug patent expiration?
More Information on Dosage

SEASONIQUE family patents

Family Patents

8. Twirla patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8883196 AGILE Transdermal hormone delivery system: compositions and methods
Nov, 2020

(3 years ago)

US8221785 AGILE Transdermal hormone delivery system: compositions and methods
Mar, 2021

(3 years ago)

US7045145 AGILE Transdermal contraceptive delivery system and process
Mar, 2021

(3 years ago)

US8221784 AGILE Transdermal hormone delivery system: compositions and methods
Mar, 2021

(3 years ago)

US7384650 AGILE Skin permeation enhancement composition for transdermal hormone delivery system
Mar, 2021

(3 years ago)

US9050348 AGILE Dermal delivery device
Jul, 2028

(4 years from now)

US8747888 AGILE Dermal delivery device with in situ seal
Jul, 2028

(4 years from now)

US8246978 AGILE Dermal delivery device with reduced loss of its volatile components
Aug, 2028

(4 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Product(NP) Feb 14, 2023

Market Authorisation Date: 14 February, 2020

Treatment: A transdermal method of contraception

Dosage: SYSTEM;TRANSDERMAL

More Information on Dosage

TWIRLA family patents

Family Patents